nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—Clobazam—epilepsy syndrome	0.15	0.518	CrCtD
Loxapine—Diazepam—epilepsy syndrome	0.14	0.482	CrCtD
Loxapine—schizophrenia—Lamotrigine—epilepsy syndrome	0.0675	0.332	CpDpCtD
Loxapine—schizophrenia—Carbamazepine—epilepsy syndrome	0.0512	0.252	CpDpCtD
Loxapine—schizophrenia—Valproic Acid—epilepsy syndrome	0.0435	0.214	CpDpCtD
Loxapine—schizophrenia—Clonazepam—epilepsy syndrome	0.0409	0.201	CpDpCtD
Loxapine—CHRM3—epilepsy syndrome	0.0336	0.201	CbGaD
Loxapine—CHRM1—epilepsy syndrome	0.0313	0.187	CbGaD
Loxapine—CHRM2—epilepsy syndrome	0.0256	0.153	CbGaD
Loxapine—HTR7—epilepsy syndrome	0.0254	0.152	CbGaD
Loxapine—ADRA2A—epilepsy syndrome	0.0218	0.131	CbGaD
Loxapine—SLC6A4—epilepsy syndrome	0.0166	0.0996	CbGaD
Loxapine—HTR2A—epilepsy syndrome	0.0128	0.0765	CbGaD
Loxapine—Pirenzepine—Oxcarbazepine—epilepsy syndrome	0.0102	0.0515	CrCrCtD
Loxapine—Cyproheptadine—Carbamazepine—epilepsy syndrome	0.00852	0.0431	CrCrCtD
Loxapine—Amoxapine—Diazepam—epilepsy syndrome	0.00699	0.0354	CrCrCtD
Loxapine—Chlordiazepoxide—Midazolam—epilepsy syndrome	0.00668	0.0338	CrCrCtD
Loxapine—Chlordiazepoxide—Clobazam—epilepsy syndrome	0.00641	0.0324	CrCrCtD
Loxapine—Alprazolam—Clonazepam—epilepsy syndrome	0.00633	0.032	CrCrCtD
Loxapine—Alprazolam—Midazolam—epilepsy syndrome	0.00603	0.0305	CrCrCtD
Loxapine—Chlordiazepoxide—Diazepam—epilepsy syndrome	0.00596	0.0301	CrCrCtD
Loxapine—Alprazolam—Clobazam—epilepsy syndrome	0.00579	0.0293	CrCrCtD
Loxapine—Clozapine—Clonazepam—epilepsy syndrome	0.00562	0.0284	CrCrCtD
Loxapine—Alprazolam—Diazepam—epilepsy syndrome	0.00538	0.0272	CrCrCtD
Loxapine—Temazepam—Midazolam—epilepsy syndrome	0.00536	0.0271	CrCrCtD
Loxapine—Clobazam—Oxcarbazepine—epilepsy syndrome	0.00522	0.0264	CrCrCtD
Loxapine—Clobazam—Midazolam—epilepsy syndrome	0.00522	0.0264	CrCrCtD
Loxapine—Prazepam—Clonazepam—epilepsy syndrome	0.00519	0.0262	CrCrCtD
Loxapine—Fludiazepam—Clonazepam—epilepsy syndrome	0.00519	0.0262	CrCrCtD
Loxapine—Temazepam—Clobazam—epilepsy syndrome	0.00514	0.026	CrCrCtD
Loxapine—Chlorcyclizine—Clobazam—epilepsy syndrome	0.00514	0.026	CrCrCtD
Loxapine—Clozapine—Clobazam—epilepsy syndrome	0.00514	0.026	CrCrCtD
Loxapine—Prazepam—Midazolam—epilepsy syndrome	0.00495	0.025	CrCrCtD
Loxapine—Fludiazepam—Midazolam—epilepsy syndrome	0.00495	0.025	CrCrCtD
Loxapine—Delorazepam—Clonazepam—epilepsy syndrome	0.00495	0.025	CrCrCtD
Loxapine—Clozapine—Diazepam—epilepsy syndrome	0.00478	0.0241	CrCrCtD
Loxapine—Temazepam—Diazepam—epilepsy syndrome	0.00478	0.0241	CrCrCtD
Loxapine—Prazepam—Clobazam—epilepsy syndrome	0.00475	0.024	CrCrCtD
Loxapine—Fludiazepam—Clobazam—epilepsy syndrome	0.00475	0.024	CrCrCtD
Loxapine—Diazepam—Clonazepam—epilepsy syndrome	0.00472	0.0239	CrCrCtD
Loxapine—Delorazepam—Midazolam—epilepsy syndrome	0.00472	0.0239	CrCrCtD
Loxapine—Clobazam—Diazepam—epilepsy syndrome	0.00465	0.0235	CrCrCtD
Loxapine—Delorazepam—Clobazam—epilepsy syndrome	0.00452	0.0229	CrCrCtD
Loxapine—Diazepam—Oxcarbazepine—epilepsy syndrome	0.00451	0.0228	CrCrCtD
Loxapine—Diazepam—Midazolam—epilepsy syndrome	0.00451	0.0228	CrCrCtD
Loxapine—Fludiazepam—Diazepam—epilepsy syndrome	0.00441	0.0223	CrCrCtD
Loxapine—Prazepam—Diazepam—epilepsy syndrome	0.00441	0.0223	CrCrCtD
Loxapine—Diazepam—Clobazam—epilepsy syndrome	0.00432	0.0218	CrCrCtD
Loxapine—Delorazepam—Diazepam—epilepsy syndrome	0.00421	0.0213	CrCrCtD
Loxapine—Prochlorperazine—Clobazam—epilepsy syndrome	0.00343	0.0174	CrCrCtD
Loxapine—HTR7—vagus nerve—epilepsy syndrome	0.000452	0.0155	CbGeAlD
Loxapine—DRD1—telencephalic ventricle—epilepsy syndrome	0.000448	0.0154	CbGeAlD
Loxapine—HTR6—ganglion—epilepsy syndrome	0.000375	0.0129	CbGeAlD
Loxapine—HTR2A—locus ceruleus—epilepsy syndrome	0.000368	0.0126	CbGeAlD
Loxapine—DRD5—ganglion—epilepsy syndrome	0.000365	0.0125	CbGeAlD
Loxapine—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000363	0.0125	CbGeAlD
Loxapine—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00036	0.0124	CbGeAlD
Loxapine—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000351	0.0121	CbGeAlD
Loxapine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000348	0.0119	CbGeAlD
Loxapine—HTR7—pons—epilepsy syndrome	0.00034	0.0117	CbGeAlD
Loxapine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000325	0.0112	CbGeAlD
Loxapine—HTR7—autonomic nervous system—epilepsy syndrome	0.000314	0.0108	CbGeAlD
Loxapine—HTR2A—cerebellar cortex—epilepsy syndrome	0.0003	0.0103	CbGeAlD
Loxapine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000293	0.0101	CbGeAlD
Loxapine—HTR2A—vagus nerve—epilepsy syndrome	0.000282	0.00968	CbGeAlD
Loxapine—HTR7—telencephalic ventricle—epilepsy syndrome	0.00028	0.00961	CbGeAlD
Loxapine—DRD1—ganglion—epilepsy syndrome	0.000279	0.00957	CbGeAlD
Loxapine—HTR3A—ganglion—epilepsy syndrome	0.000269	0.00925	CbGeAlD
Loxapine—HTR5A—head—epilepsy syndrome	0.000269	0.00923	CbGeAlD
Loxapine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000265	0.00909	CbGeAlD
Loxapine—HTR5A—nervous system—epilepsy syndrome	0.000255	0.00875	CbGeAlD
Loxapine—HTR5A—central nervous system—epilepsy syndrome	0.000245	0.00842	CbGeAlD
Loxapine—HTR1B—ganglion—epilepsy syndrome	0.000226	0.00776	CbGeAlD
Loxapine—SLC6A3—ganglion—epilepsy syndrome	0.000224	0.00769	CbGeAlD
Loxapine—HTR1D—ganglion—epilepsy syndrome	0.000219	0.00751	CbGeAlD
Loxapine—HTR2C—ganglion—epilepsy syndrome	0.000217	0.00744	CbGeAlD
Loxapine—HTR2A—pons—epilepsy syndrome	0.000212	0.00728	CbGeAlD
Loxapine—HTR1E—brainstem—epilepsy syndrome	0.000208	0.00713	CbGeAlD
Loxapine—SLC6A4—ganglion—epilepsy syndrome	0.000205	0.00705	CbGeAlD
Loxapine—HTR1E—forebrain—epilepsy syndrome	0.0002	0.00688	CbGeAlD
Loxapine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000196	0.00672	CbGeAlD
Loxapine—HTR5A—brain—epilepsy syndrome	0.000195	0.00669	CbGeAlD
Loxapine—HTR1E—telencephalon—epilepsy syndrome	0.000184	0.00633	CbGeAlD
Loxapine—HTR1A—ganglion—epilepsy syndrome	0.000182	0.00626	CbGeAlD
Loxapine—SLC6A2—ganglion—epilepsy syndrome	0.000181	0.00621	CbGeAlD
Loxapine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000175	0.00599	CbGeAlD
Loxapine—HTR7—ganglion—epilepsy syndrome	0.000174	0.00598	CbGeAlD
Loxapine—SLC6A3—hindbrain—epilepsy syndrome	0.00017	0.00583	CbGeAlD
Loxapine—DRD2—ganglion—epilepsy syndrome	0.000165	0.00566	CbGeAlD
Loxapine—HTR6—forebrain—epilepsy syndrome	0.000157	0.0054	CbGeAlD
Loxapine—SLC6A4—hindbrain—epilepsy syndrome	0.000156	0.00535	CbGeAlD
Loxapine—DRD5—forebrain—epilepsy syndrome	0.000153	0.00526	CbGeAlD
Loxapine—HTR6—telencephalon—epilepsy syndrome	0.000145	0.00496	CbGeAlD
Loxapine—DRD5—telencephalon—epilepsy syndrome	0.000141	0.00483	CbGeAlD
Loxapine—HTR1A—hindbrain—epilepsy syndrome	0.000138	0.00475	CbGeAlD
Loxapine—HTR7—hindbrain—epilepsy syndrome	0.000132	0.00454	CbGeAlD
Loxapine—ADRA1A—hindbrain—epilepsy syndrome	0.000127	0.00438	CbGeAlD
Loxapine—DRD2—hindbrain—epilepsy syndrome	0.000125	0.00429	CbGeAlD
Loxapine—DRD1—brainstem—epilepsy syndrome	0.000121	0.00416	CbGeAlD
Loxapine—HTR3A—brainstem—epilepsy syndrome	0.000117	0.00402	CbGeAlD
Loxapine—DRD1—forebrain—epilepsy syndrome	0.000117	0.00402	CbGeAlD
Loxapine—HTR1E—head—epilepsy syndrome	0.000115	0.00394	CbGeAlD
Loxapine—HTR3A—forebrain—epilepsy syndrome	0.000113	0.00388	CbGeAlD
Loxapine—HTR1E—nervous system—epilepsy syndrome	0.000109	0.00373	CbGeAlD
Loxapine—HTR2A—ganglion—epilepsy syndrome	0.000109	0.00373	CbGeAlD
Loxapine—DRD1—telencephalon—epilepsy syndrome	0.000108	0.00369	CbGeAlD
Loxapine—HTR1E—central nervous system—epilepsy syndrome	0.000105	0.0036	CbGeAlD
Loxapine—HTR3A—telencephalon—epilepsy syndrome	0.000104	0.00357	CbGeAlD
Loxapine—CHRM4—head—epilepsy syndrome	0.000101	0.00345	CbGeAlD
Loxapine—HTR1B—brainstem—epilepsy syndrome	9.82e-05	0.00337	CbGeAlD
Loxapine—SLC6A3—brainstem—epilepsy syndrome	9.74e-05	0.00334	CbGeAlD
Loxapine—DRD4—brain—epilepsy syndrome	9.64e-05	0.00331	CbGeAlD
Loxapine—CHRM4—nervous system—epilepsy syndrome	9.54e-05	0.00327	CbGeAlD
Loxapine—HTR1D—brainstem—epilepsy syndrome	9.51e-05	0.00326	CbGeAlD
Loxapine—HTR1B—forebrain—epilepsy syndrome	9.48e-05	0.00325	CbGeAlD
Loxapine—CHRM2—forebrain—epilepsy syndrome	9.43e-05	0.00324	CbGeAlD
Loxapine—HTR2C—brainstem—epilepsy syndrome	9.41e-05	0.00323	CbGeAlD
Loxapine—SLC6A3—forebrain—epilepsy syndrome	9.4e-05	0.00323	CbGeAlD
Loxapine—DRD3—head—epilepsy syndrome	9.35e-05	0.00321	CbGeAlD
Loxapine—CHRM4—central nervous system—epilepsy syndrome	9.18e-05	0.00315	CbGeAlD
Loxapine—HTR1D—forebrain—epilepsy syndrome	9.18e-05	0.00315	CbGeAlD
Loxapine—HTR2C—forebrain—epilepsy syndrome	9.09e-05	0.00312	CbGeAlD
Loxapine—HTR6—head—epilepsy syndrome	9e-05	0.00309	CbGeAlD
Loxapine—SLC6A4—brainstem—epilepsy syndrome	8.92e-05	0.00306	CbGeAlD
Loxapine—ADRB1—forebrain—epilepsy syndrome	8.92e-05	0.00306	CbGeAlD
Loxapine—DRD3—nervous system—epilepsy syndrome	8.87e-05	0.00304	CbGeAlD
Loxapine—DRD5—head—epilepsy syndrome	8.76e-05	0.00301	CbGeAlD
Loxapine—HTR1B—telencephalon—epilepsy syndrome	8.71e-05	0.00299	CbGeAlD
Loxapine—CHRM2—telencephalon—epilepsy syndrome	8.67e-05	0.00298	CbGeAlD
Loxapine—SLC6A3—telencephalon—epilepsy syndrome	8.64e-05	0.00297	CbGeAlD
Loxapine—SLC6A4—forebrain—epilepsy syndrome	8.61e-05	0.00296	CbGeAlD
Loxapine—CHRM1—forebrain—epilepsy syndrome	8.58e-05	0.00295	CbGeAlD
Loxapine—DRD3—central nervous system—epilepsy syndrome	8.54e-05	0.00293	CbGeAlD
Loxapine—HTR6—nervous system—epilepsy syndrome	8.54e-05	0.00293	CbGeAlD
Loxapine—HTR1D—telencephalon—epilepsy syndrome	8.44e-05	0.0029	CbGeAlD
Loxapine—HTR2C—telencephalon—epilepsy syndrome	8.35e-05	0.00287	CbGeAlD
Loxapine—HTR1E—brain—epilepsy syndrome	8.31e-05	0.00285	CbGeAlD
Loxapine—DRD5—nervous system—epilepsy syndrome	8.31e-05	0.00285	CbGeAlD
Loxapine—HTR2A—hindbrain—epilepsy syndrome	8.24e-05	0.00283	CbGeAlD
Loxapine—HRH2—head—epilepsy syndrome	8.23e-05	0.00283	CbGeAlD
Loxapine—HTR6—central nervous system—epilepsy syndrome	8.22e-05	0.00282	CbGeAlD
Loxapine—ADRB1—telencephalon—epilepsy syndrome	8.2e-05	0.00281	CbGeAlD
Loxapine—DRD5—central nervous system—epilepsy syndrome	8e-05	0.00275	CbGeAlD
Loxapine—HTR1A—brainstem—epilepsy syndrome	7.92e-05	0.00272	CbGeAlD
Loxapine—SLC6A4—telencephalon—epilepsy syndrome	7.92e-05	0.00272	CbGeAlD
Loxapine—CHRM1—telencephalon—epilepsy syndrome	7.89e-05	0.00271	CbGeAlD
Loxapine—CHRM5—head—epilepsy syndrome	7.86e-05	0.0027	CbGeAlD
Loxapine—SLC6A2—brainstem—epilepsy syndrome	7.86e-05	0.0027	CbGeAlD
Loxapine—HRH2—nervous system—epilepsy syndrome	7.8e-05	0.00268	CbGeAlD
Loxapine—DRD1—midbrain—epilepsy syndrome	7.72e-05	0.00265	CbGeAlD
Loxapine—CHRM3—forebrain—epilepsy syndrome	7.68e-05	0.00264	CbGeAlD
Loxapine—HTR1A—forebrain—epilepsy syndrome	7.65e-05	0.00263	CbGeAlD
Loxapine—SLC6A2—forebrain—epilepsy syndrome	7.58e-05	0.0026	CbGeAlD
Loxapine—HTR7—brainstem—epilepsy syndrome	7.57e-05	0.0026	CbGeAlD
Loxapine—HRH2—central nervous system—epilepsy syndrome	7.51e-05	0.00258	CbGeAlD
Loxapine—CHRM5—nervous system—epilepsy syndrome	7.46e-05	0.00256	CbGeAlD
Loxapine—HTR7—forebrain—epilepsy syndrome	7.31e-05	0.00251	CbGeAlD
Loxapine—ADRA1A—brainstem—epilepsy syndrome	7.3e-05	0.00251	CbGeAlD
Loxapine—CHRM4—brain—epilepsy syndrome	7.29e-05	0.0025	CbGeAlD
Loxapine—ADRA1B—head—epilepsy syndrome	7.18e-05	0.00247	CbGeAlD
Loxapine—CHRM5—central nervous system—epilepsy syndrome	7.18e-05	0.00246	CbGeAlD
Loxapine—DRD2—brainstem—epilepsy syndrome	7.16e-05	0.00246	CbGeAlD
Loxapine—CHRM3—telencephalon—epilepsy syndrome	7.06e-05	0.00242	CbGeAlD
Loxapine—ADRA1A—forebrain—epilepsy syndrome	7.05e-05	0.00242	CbGeAlD
Loxapine—HTR1A—telencephalon—epilepsy syndrome	7.03e-05	0.00241	CbGeAlD
Loxapine—SLC6A2—telencephalon—epilepsy syndrome	6.97e-05	0.00239	CbGeAlD
Loxapine—Clobazam—SLC6A1—epilepsy syndrome	6.93e-05	0.0359	CrCbGaD
Loxapine—DRD2—forebrain—epilepsy syndrome	6.91e-05	0.00237	CbGeAlD
Loxapine—ADRA1B—nervous system—epilepsy syndrome	6.81e-05	0.00234	CbGeAlD
Loxapine—DRD3—brain—epilepsy syndrome	6.78e-05	0.00233	CbGeAlD
Loxapine—HTR7—telencephalon—epilepsy syndrome	6.72e-05	0.00231	CbGeAlD
Loxapine—DRD1—head—epilepsy syndrome	6.7e-05	0.0023	CbGeAlD
Loxapine—HTR2C—medulla oblongata—epilepsy syndrome	6.56e-05	0.00225	CbGeAlD
Loxapine—ADRA1B—central nervous system—epilepsy syndrome	6.56e-05	0.00225	CbGeAlD
Loxapine—HTR6—brain—epilepsy syndrome	6.52e-05	0.00224	CbGeAlD
Loxapine—ADRA1A—telencephalon—epilepsy syndrome	6.48e-05	0.00223	CbGeAlD
Loxapine—HTR3A—head—epilepsy syndrome	6.47e-05	0.00222	CbGeAlD
Loxapine—DRD2—telencephalon—epilepsy syndrome	6.35e-05	0.00218	CbGeAlD
Loxapine—DRD5—brain—epilepsy syndrome	6.35e-05	0.00218	CbGeAlD
Loxapine—DRD1—nervous system—epilepsy syndrome	6.35e-05	0.00218	CbGeAlD
Loxapine—HTR1B—midbrain—epilepsy syndrome	6.26e-05	0.00215	CbGeAlD
Loxapine—SLC6A3—midbrain—epilepsy syndrome	6.21e-05	0.00213	CbGeAlD
Loxapine—ADRA2C—telencephalon—epilepsy syndrome	6.18e-05	0.00212	CbGeAlD
Loxapine—HTR3A—nervous system—epilepsy syndrome	6.13e-05	0.00211	CbGeAlD
Loxapine—DRD1—central nervous system—epilepsy syndrome	6.11e-05	0.0021	CbGeAlD
Loxapine—HTR1B—spinal cord—epilepsy syndrome	6.11e-05	0.0021	CbGeAlD
Loxapine—HTR1D—midbrain—epilepsy syndrome	6.06e-05	0.00208	CbGeAlD
Loxapine—SLC6A3—spinal cord—epilepsy syndrome	6.06e-05	0.00208	CbGeAlD
Loxapine—HTR2C—midbrain—epilepsy syndrome	6e-05	0.00206	CbGeAlD
Loxapine—HRH2—brain—epilepsy syndrome	5.96e-05	0.00205	CbGeAlD
Loxapine—HTR3A—central nervous system—epilepsy syndrome	5.9e-05	0.00203	CbGeAlD
Loxapine—HTR2C—spinal cord—epilepsy syndrome	5.85e-05	0.00201	CbGeAlD
Loxapine—Pirenzepine—CHRM1—epilepsy syndrome	5.71e-05	0.0296	CrCbGaD
Loxapine—CHRM5—brain—epilepsy syndrome	5.7e-05	0.00196	CbGeAlD
Loxapine—SLC6A4—midbrain—epilepsy syndrome	5.69e-05	0.00195	CbGeAlD
Loxapine—SLC6A4—spinal cord—epilepsy syndrome	5.55e-05	0.00191	CbGeAlD
Loxapine—SLC6A2—medulla oblongata—epilepsy syndrome	5.48e-05	0.00188	CbGeAlD
Loxapine—HRH1—forebrain—epilepsy syndrome	5.46e-05	0.00187	CbGeAlD
Loxapine—HTR1B—head—epilepsy syndrome	5.43e-05	0.00186	CbGeAlD
Loxapine—CHRM2—head—epilepsy syndrome	5.4e-05	0.00185	CbGeAlD
Loxapine—SLC6A3—head—epilepsy syndrome	5.38e-05	0.00185	CbGeAlD
Loxapine—ADRA2A—forebrain—epilepsy syndrome	5.36e-05	0.00184	CbGeAlD
Loxapine—HTR7—medulla oblongata—epilepsy syndrome	5.28e-05	0.00181	CbGeAlD
Loxapine—HTR1D—head—epilepsy syndrome	5.25e-05	0.0018	CbGeAlD
Loxapine—ADRA1B—brain—epilepsy syndrome	5.21e-05	0.00179	CbGeAlD
Loxapine—HTR2C—head—epilepsy syndrome	5.2e-05	0.00179	CbGeAlD
Loxapine—HTR1B—nervous system—epilepsy syndrome	5.14e-05	0.00177	CbGeAlD
Loxapine—CHRM2—nervous system—epilepsy syndrome	5.12e-05	0.00176	CbGeAlD
Loxapine—ADRB1—head—epilepsy syndrome	5.11e-05	0.00175	CbGeAlD
Loxapine—SLC6A3—nervous system—epilepsy syndrome	5.1e-05	0.00175	CbGeAlD
Loxapine—HTR1A—midbrain—epilepsy syndrome	5.05e-05	0.00173	CbGeAlD
Loxapine—HRH1—telencephalon—epilepsy syndrome	5.02e-05	0.00172	CbGeAlD
Loxapine—HTR1D—nervous system—epilepsy syndrome	4.98e-05	0.00171	CbGeAlD
Loxapine—HTR1B—central nervous system—epilepsy syndrome	4.95e-05	0.0017	CbGeAlD
Loxapine—Azelastine—HRH3—epilepsy syndrome	4.94e-05	0.0256	CrCbGaD
Loxapine—HTR2C—nervous system—epilepsy syndrome	4.93e-05	0.00169	CbGeAlD
Loxapine—SLC6A4—head—epilepsy syndrome	4.93e-05	0.00169	CbGeAlD
Loxapine—ADRA2A—telencephalon—epilepsy syndrome	4.93e-05	0.00169	CbGeAlD
Loxapine—HTR1A—spinal cord—epilepsy syndrome	4.93e-05	0.00169	CbGeAlD
Loxapine—CHRM2—central nervous system—epilepsy syndrome	4.93e-05	0.00169	CbGeAlD
Loxapine—CHRM1—head—epilepsy syndrome	4.91e-05	0.00169	CbGeAlD
Loxapine—SLC6A3—central nervous system—epilepsy syndrome	4.91e-05	0.00169	CbGeAlD
Loxapine—ADRA2C—medulla oblongata—epilepsy syndrome	4.85e-05	0.00167	CbGeAlD
Loxapine—DRD1—brain—epilepsy syndrome	4.85e-05	0.00167	CbGeAlD
Loxapine—ADRB1—nervous system—epilepsy syndrome	4.84e-05	0.00166	CbGeAlD
Loxapine—HTR7—midbrain—epilepsy syndrome	4.83e-05	0.00166	CbGeAlD
Loxapine—SLC6A3—cerebellum—epilepsy syndrome	4.8e-05	0.00165	CbGeAlD
Loxapine—HTR1D—central nervous system—epilepsy syndrome	4.8e-05	0.00165	CbGeAlD
Loxapine—HTR2C—central nervous system—epilepsy syndrome	4.75e-05	0.00163	CbGeAlD
Loxapine—HTR2A—brainstem—epilepsy syndrome	4.72e-05	0.00162	CbGeAlD
Loxapine—HTR7—spinal cord—epilepsy syndrome	4.71e-05	0.00162	CbGeAlD
Loxapine—HTR3A—brain—epilepsy syndrome	4.69e-05	0.00161	CbGeAlD
Loxapine—SLC6A4—nervous system—epilepsy syndrome	4.68e-05	0.00161	CbGeAlD
Loxapine—ADRB1—central nervous system—epilepsy syndrome	4.66e-05	0.0016	CbGeAlD
Loxapine—CHRM1—nervous system—epilepsy syndrome	4.66e-05	0.0016	CbGeAlD
Loxapine—DRD2—midbrain—epilepsy syndrome	4.56e-05	0.00157	CbGeAlD
Loxapine—HTR2A—forebrain—epilepsy syndrome	4.56e-05	0.00156	CbGeAlD
Loxapine—SLC6A4—central nervous system—epilepsy syndrome	4.5e-05	0.00155	CbGeAlD
Loxapine—CHRM1—central nervous system—epilepsy syndrome	4.48e-05	0.00154	CbGeAlD
Loxapine—ADRA2C—midbrain—epilepsy syndrome	4.44e-05	0.00152	CbGeAlD
Loxapine—CHRM3—head—epilepsy syndrome	4.4e-05	0.00151	CbGeAlD
Loxapine—HTR1A—head—epilepsy syndrome	4.38e-05	0.0015	CbGeAlD
Loxapine—SLC6A2—head—epilepsy syndrome	4.34e-05	0.00149	CbGeAlD
Loxapine—ADRA2C—spinal cord—epilepsy syndrome	4.33e-05	0.00149	CbGeAlD
Loxapine—HTR2A—telencephalon—epilepsy syndrome	4.19e-05	0.00144	CbGeAlD
Loxapine—HTR7—head—epilepsy syndrome	4.18e-05	0.00144	CbGeAlD
Loxapine—CHRM3—nervous system—epilepsy syndrome	4.17e-05	0.00143	CbGeAlD
Loxapine—HTR1A—nervous system—epilepsy syndrome	4.15e-05	0.00143	CbGeAlD
Loxapine—SLC6A2—nervous system—epilepsy syndrome	4.12e-05	0.00141	CbGeAlD
Loxapine—ADRA1A—head—epilepsy syndrome	4.04e-05	0.00139	CbGeAlD
Loxapine—CHRM3—central nervous system—epilepsy syndrome	4.01e-05	0.00138	CbGeAlD
Loxapine—HTR1A—central nervous system—epilepsy syndrome	4e-05	0.00137	CbGeAlD
Loxapine—HTR7—nervous system—epilepsy syndrome	3.97e-05	0.00136	CbGeAlD
Loxapine—SLC6A2—central nervous system—epilepsy syndrome	3.96e-05	0.00136	CbGeAlD
Loxapine—DRD2—head—epilepsy syndrome	3.96e-05	0.00136	CbGeAlD
Loxapine—Chlordiazepoxide—GABRG2—epilepsy syndrome	3.93e-05	0.0204	CrCbGaD
Loxapine—HTR1B—brain—epilepsy syndrome	3.93e-05	0.00135	CbGeAlD
Loxapine—CHRM2—brain—epilepsy syndrome	3.91e-05	0.00134	CbGeAlD
Loxapine—HTR1A—cerebellum—epilepsy syndrome	3.91e-05	0.00134	CbGeAlD
Loxapine—SLC6A3—brain—epilepsy syndrome	3.9e-05	0.00134	CbGeAlD
Loxapine—ADRA2A—medulla oblongata—epilepsy syndrome	3.87e-05	0.00133	CbGeAlD
Loxapine—ADRA2C—head—epilepsy syndrome	3.85e-05	0.00132	CbGeAlD
Loxapine—ADRA1A—nervous system—epilepsy syndrome	3.83e-05	0.00131	CbGeAlD
Loxapine—HTR7—central nervous system—epilepsy syndrome	3.82e-05	0.00131	CbGeAlD
Loxapine—HTR1D—brain—epilepsy syndrome	3.81e-05	0.00131	CbGeAlD
Loxapine—HTR2C—brain—epilepsy syndrome	3.77e-05	0.00129	CbGeAlD
Loxapine—DRD2—nervous system—epilepsy syndrome	3.75e-05	0.00129	CbGeAlD
Loxapine—HTR7—cerebellum—epilepsy syndrome	3.73e-05	0.00128	CbGeAlD
Loxapine—ADRB1—brain—epilepsy syndrome	3.7e-05	0.00127	CbGeAlD
Loxapine—ADRA1A—central nervous system—epilepsy syndrome	3.68e-05	0.00127	CbGeAlD
Loxapine—ADRA2C—nervous system—epilepsy syndrome	3.65e-05	0.00125	CbGeAlD
Loxapine—DRD2—central nervous system—epilepsy syndrome	3.61e-05	0.00124	CbGeAlD
Loxapine—ADRA1A—cerebellum—epilepsy syndrome	3.6e-05	0.00124	CbGeAlD
Loxapine—SLC6A4—brain—epilepsy syndrome	3.57e-05	0.00123	CbGeAlD
Loxapine—CHRM1—brain—epilepsy syndrome	3.56e-05	0.00122	CbGeAlD
Loxapine—Fludiazepam—GABRD—epilepsy syndrome	3.55e-05	0.0184	CrCbGaD
Loxapine—ADRA2A—midbrain—epilepsy syndrome	3.54e-05	0.00122	CbGeAlD
Loxapine—DRD2—cerebellum—epilepsy syndrome	3.53e-05	0.00121	CbGeAlD
Loxapine—ADRA2C—central nervous system—epilepsy syndrome	3.51e-05	0.00121	CbGeAlD
Loxapine—Prazepam—GABRD—epilepsy syndrome	3.46e-05	0.0179	CrCbGaD
Loxapine—Asenapine—HTR7—epilepsy syndrome	3.46e-05	0.0179	CrCbGaD
Loxapine—ADRA2A—spinal cord—epilepsy syndrome	3.45e-05	0.00119	CbGeAlD
Loxapine—ADRA2C—cerebellum—epilepsy syndrome	3.43e-05	0.00118	CbGeAlD
Loxapine—Alprazolam—GABRG2—epilepsy syndrome	3.33e-05	0.0172	CrCbGaD
Loxapine—Clobazam—GABRG2—epilepsy syndrome	3.33e-05	0.0172	CrCbGaD
Loxapine—HTR2A—medulla oblongata—epilepsy syndrome	3.29e-05	0.00113	CbGeAlD
Loxapine—CHRM3—brain—epilepsy syndrome	3.19e-05	0.00109	CbGeAlD
Loxapine—HTR1A—brain—epilepsy syndrome	3.17e-05	0.00109	CbGeAlD
Loxapine—Chlordiazepoxide—GABRB3—epilepsy syndrome	3.17e-05	0.0164	CrCbGaD
Loxapine—Chlordiazepoxide—GABRA5—epilepsy syndrome	3.17e-05	0.0164	CrCbGaD
Loxapine—SLC6A2—brain—epilepsy syndrome	3.15e-05	0.00108	CbGeAlD
Loxapine—HRH1—head—epilepsy syndrome	3.12e-05	0.00107	CbGeAlD
Loxapine—Temazepam—GABRD—epilepsy syndrome	3.09e-05	0.016	CrCbGaD
Loxapine—ADRA2A—head—epilepsy syndrome	3.07e-05	0.00105	CbGeAlD
Loxapine—HTR7—brain—epilepsy syndrome	3.03e-05	0.00104	CbGeAlD
Loxapine—HTR2A—midbrain—epilepsy syndrome	3.01e-05	0.00103	CbGeAlD
Loxapine—Asenapine—ADRA2A—epilepsy syndrome	2.97e-05	0.0154	CrCbGaD
Loxapine—HRH1—nervous system—epilepsy syndrome	2.96e-05	0.00102	CbGeAlD
Loxapine—HTR2A—spinal cord—epilepsy syndrome	2.94e-05	0.00101	CbGeAlD
Loxapine—ADRA1A—brain—epilepsy syndrome	2.93e-05	0.001	CbGeAlD
Loxapine—ADRA2A—nervous system—epilepsy syndrome	2.91e-05	0.000999	CbGeAlD
Loxapine—DRD2—brain—epilepsy syndrome	2.87e-05	0.000985	CbGeAlD
Loxapine—HRH1—central nervous system—epilepsy syndrome	2.85e-05	0.000979	CbGeAlD
Loxapine—ADRA2A—central nervous system—epilepsy syndrome	2.8e-05	0.000962	CbGeAlD
Loxapine—ADRA2C—brain—epilepsy syndrome	2.79e-05	0.000957	CbGeAlD
Loxapine—Chlordiazepoxide—GABRB2—epilepsy syndrome	2.77e-05	0.0143	CrCbGaD
Loxapine—ADRA2A—cerebellum—epilepsy syndrome	2.74e-05	0.00094	CbGeAlD
Loxapine—Chlordiazepoxide—GABRA1—epilepsy syndrome	2.72e-05	0.0141	CrCbGaD
Loxapine—Fludiazepam—GABRG2—epilepsy syndrome	2.69e-05	0.0139	CrCbGaD
Loxapine—Alprazolam—GABRA5—epilepsy syndrome	2.68e-05	0.0139	CrCbGaD
Loxapine—Alprazolam—GABRB3—epilepsy syndrome	2.68e-05	0.0139	CrCbGaD
Loxapine—Prazepam—GABRG2—epilepsy syndrome	2.63e-05	0.0136	CrCbGaD
Loxapine—Cyproheptadine—CHRM3—epilepsy syndrome	2.62e-05	0.0136	CrCbGaD
Loxapine—HTR2A—head—epilepsy syndrome	2.61e-05	0.000896	CbGeAlD
Loxapine—Asthenia—Diazepam—epilepsy syndrome	2.6e-05	0.00044	CcSEcCtD
Loxapine—Constipation—Lamotrigine—epilepsy syndrome	2.59e-05	0.000438	CcSEcCtD
Loxapine—Renal failure—Topiramate—epilepsy syndrome	2.58e-05	0.000438	CcSEcCtD
Loxapine—Nausea—Acetazolamide—epilepsy syndrome	2.58e-05	0.000438	CcSEcCtD
Loxapine—Dizziness—Levetiracetam—epilepsy syndrome	2.58e-05	0.000437	CcSEcCtD
Loxapine—Feeling abnormal—Carbamazepine—epilepsy syndrome	2.58e-05	0.000437	CcSEcCtD
Loxapine—Cough—Valproic Acid—epilepsy syndrome	2.57e-05	0.000436	CcSEcCtD
Loxapine—Vomiting—Propofol—epilepsy syndrome	2.57e-05	0.000435	CcSEcCtD
Loxapine—Diazepam—GABRD—epilepsy syndrome	2.57e-05	0.0133	CrCbGaD
Loxapine—Muscle spasms—Pregabalin—epilepsy syndrome	2.56e-05	0.000434	CcSEcCtD
Loxapine—Pruritus—Diazepam—epilepsy syndrome	2.56e-05	0.000434	CcSEcCtD
Loxapine—Rash—Propofol—epilepsy syndrome	2.55e-05	0.000432	CcSEcCtD
Loxapine—Dermatitis—Propofol—epilepsy syndrome	2.55e-05	0.000431	CcSEcCtD
Loxapine—Hypertension—Valproic Acid—epilepsy syndrome	2.54e-05	0.000431	CcSEcCtD
Loxapine—Olanzapine—CHRM3—epilepsy syndrome	2.54e-05	0.0132	CrCbGaD
Loxapine—Headache—Propofol—epilepsy syndrome	2.53e-05	0.000429	CcSEcCtD
Loxapine—Mediastinal disorder—Gabapentin—epilepsy syndrome	2.53e-05	0.000428	CcSEcCtD
Loxapine—Hypersensitivity—Zonisamide—epilepsy syndrome	2.52e-05	0.000428	CcSEcCtD
Loxapine—Vomiting—Midazolam—epilepsy syndrome	2.51e-05	0.000426	CcSEcCtD
Loxapine—Asthenia—Felbamate—epilepsy syndrome	2.51e-05	0.000425	CcSEcCtD
Loxapine—Vision blurred—Pregabalin—epilepsy syndrome	2.51e-05	0.000425	CcSEcCtD
Loxapine—Chest pain—Valproic Acid—epilepsy syndrome	2.51e-05	0.000425	CcSEcCtD
Loxapine—Tremor—Pregabalin—epilepsy syndrome	2.5e-05	0.000423	CcSEcCtD
Loxapine—Feeling abnormal—Lamotrigine—epilepsy syndrome	2.49e-05	0.000422	CcSEcCtD
Loxapine—Rash—Midazolam—epilepsy syndrome	2.49e-05	0.000422	CcSEcCtD
Loxapine—Dizziness—Fosphenytoin—epilepsy syndrome	2.49e-05	0.000422	CcSEcCtD
Loxapine—Dermatitis—Midazolam—epilepsy syndrome	2.49e-05	0.000422	CcSEcCtD
Loxapine—Vomiting—Levetiracetam—epilepsy syndrome	2.48e-05	0.000421	CcSEcCtD
Loxapine—Alopecia—Gabapentin—epilepsy syndrome	2.48e-05	0.00042	CcSEcCtD
Loxapine—Headache—Midazolam—epilepsy syndrome	2.48e-05	0.00042	CcSEcCtD
Loxapine—Pruritus—Felbamate—epilepsy syndrome	2.48e-05	0.00042	CcSEcCtD
Loxapine—HTR2A—nervous system—epilepsy syndrome	2.47e-05	0.00085	CbGeAlD
Loxapine—Rash—Levetiracetam—epilepsy syndrome	2.46e-05	0.000417	CcSEcCtD
Loxapine—Dermatitis—Levetiracetam—epilepsy syndrome	2.46e-05	0.000417	CcSEcCtD
Loxapine—Asthenia—Zonisamide—epilepsy syndrome	2.46e-05	0.000416	CcSEcCtD
Loxapine—Agranulocytosis—Topiramate—epilepsy syndrome	2.45e-05	0.000416	CcSEcCtD
Loxapine—Dry mouth—Valproic Acid—epilepsy syndrome	2.45e-05	0.000416	CcSEcCtD
Loxapine—Agitation—Pregabalin—epilepsy syndrome	2.45e-05	0.000415	CcSEcCtD
Loxapine—Cyproheptadine—CHRM1—epilepsy syndrome	2.45e-05	0.0127	CrCbGaD
Loxapine—Headache—Levetiracetam—epilepsy syndrome	2.45e-05	0.000414	CcSEcCtD
Loxapine—Hypersensitivity—Clonazepam—epilepsy syndrome	2.43e-05	0.000412	CcSEcCtD
Loxapine—Dizziness—Vigabatrin—epilepsy syndrome	2.43e-05	0.000412	CcSEcCtD
Loxapine—Confusional state—Valproic Acid—epilepsy syndrome	2.42e-05	0.000411	CcSEcCtD
Loxapine—Pruritus—Zonisamide—epilepsy syndrome	2.42e-05	0.000411	CcSEcCtD
Loxapine—Hypersensitivity—Phenytoin—epilepsy syndrome	2.42e-05	0.000409	CcSEcCtD
Loxapine—Oedema—Valproic Acid—epilepsy syndrome	2.4e-05	0.000407	CcSEcCtD
Loxapine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	2.4e-05	0.000407	CcSEcCtD
Loxapine—Nausea—Propofol—epilepsy syndrome	2.4e-05	0.000407	CcSEcCtD
Loxapine—Tension—Gabapentin—epilepsy syndrome	2.4e-05	0.000406	CcSEcCtD
Loxapine—Vomiting—Fosphenytoin—epilepsy syndrome	2.4e-05	0.000406	CcSEcCtD
Loxapine—Dysgeusia—Gabapentin—epilepsy syndrome	2.39e-05	0.000405	CcSEcCtD
Loxapine—Dizziness—Diazepam—epilepsy syndrome	2.39e-05	0.000405	CcSEcCtD
Loxapine—Syncope—Pregabalin—epilepsy syndrome	2.39e-05	0.000405	CcSEcCtD
Loxapine—Leukopenia—Pregabalin—epilepsy syndrome	2.38e-05	0.000404	CcSEcCtD
Loxapine—HTR2A—central nervous system—epilepsy syndrome	2.38e-05	0.000818	CbGeAlD
Loxapine—Rash—Fosphenytoin—epilepsy syndrome	2.38e-05	0.000403	CcSEcCtD
Loxapine—Dermatitis—Fosphenytoin—epilepsy syndrome	2.37e-05	0.000402	CcSEcCtD
Loxapine—Olanzapine—CHRM1—epilepsy syndrome	2.37e-05	0.0123	CrCbGaD
Loxapine—Asthenia—Clonazepam—epilepsy syndrome	2.37e-05	0.000401	CcSEcCtD
Loxapine—Headache—Fosphenytoin—epilepsy syndrome	2.36e-05	0.0004	CcSEcCtD
Loxapine—Hepatitis—Topiramate—epilepsy syndrome	2.36e-05	0.0004	CcSEcCtD
Loxapine—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.36e-05	0.0004	CcSEcCtD
Loxapine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.35e-05	0.000399	CcSEcCtD
Loxapine—Asthenia—Phenytoin—epilepsy syndrome	2.35e-05	0.000399	CcSEcCtD
Loxapine—Nausea—Midazolam—epilepsy syndrome	2.35e-05	0.000398	CcSEcCtD
Loxapine—Hypoaesthesia—Topiramate—epilepsy syndrome	2.35e-05	0.000398	CcSEcCtD
Loxapine—Muscle spasms—Gabapentin—epilepsy syndrome	2.35e-05	0.000398	CcSEcCtD
Loxapine—Tachycardia—Valproic Acid—epilepsy syndrome	2.35e-05	0.000398	CcSEcCtD
Loxapine—Alprazolam—GABRB2—epilepsy syndrome	2.35e-05	0.0121	CrCbGaD
Loxapine—Clobazam—GABRB2—epilepsy syndrome	2.35e-05	0.0121	CrCbGaD
Loxapine—Loss of consciousness—Pregabalin—epilepsy syndrome	2.34e-05	0.000397	CcSEcCtD
Loxapine—Asthenia—Oxcarbazepine—epilepsy syndrome	2.34e-05	0.000397	CcSEcCtD
Loxapine—Temazepam—GABRG2—epilepsy syndrome	2.34e-05	0.0121	CrCbGaD
Loxapine—Pruritus—Clonazepam—epilepsy syndrome	2.34e-05	0.000396	CcSEcCtD
Loxapine—Vomiting—Vigabatrin—epilepsy syndrome	2.34e-05	0.000396	CcSEcCtD
Loxapine—HTR2A—cerebellum—epilepsy syndrome	2.33e-05	0.000799	CbGeAlD
Loxapine—Cough—Pregabalin—epilepsy syndrome	2.32e-05	0.000394	CcSEcCtD
Loxapine—Pruritus—Phenytoin—epilepsy syndrome	2.32e-05	0.000393	CcSEcCtD
Loxapine—Nausea—Levetiracetam—epilepsy syndrome	2.32e-05	0.000393	CcSEcCtD
Loxapine—Rash—Vigabatrin—epilepsy syndrome	2.32e-05	0.000392	CcSEcCtD
Loxapine—Dizziness—Felbamate—epilepsy syndrome	2.31e-05	0.000392	CcSEcCtD
Loxapine—Dermatitis—Vigabatrin—epilepsy syndrome	2.31e-05	0.000392	CcSEcCtD
Loxapine—Pruritus—Oxcarbazepine—epilepsy syndrome	2.31e-05	0.000391	CcSEcCtD
Loxapine—Convulsion—Pregabalin—epilepsy syndrome	2.31e-05	0.000391	CcSEcCtD
Loxapine—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.31e-05	0.000391	CcSEcCtD
Loxapine—Vision blurred—Gabapentin—epilepsy syndrome	2.3e-05	0.00039	CcSEcCtD
Loxapine—Headache—Vigabatrin—epilepsy syndrome	2.3e-05	0.00039	CcSEcCtD
Loxapine—Clobazam—GABRA1—epilepsy syndrome	2.3e-05	0.0119	CrCbGaD
Loxapine—Alprazolam—GABRA1—epilepsy syndrome	2.3e-05	0.0119	CrCbGaD
Loxapine—Hypertension—Pregabalin—epilepsy syndrome	2.3e-05	0.00039	CcSEcCtD
Loxapine—Vomiting—Diazepam—epilepsy syndrome	2.3e-05	0.00039	CcSEcCtD
Loxapine—Tremor—Gabapentin—epilepsy syndrome	2.29e-05	0.000388	CcSEcCtD
Loxapine—Rash—Diazepam—epilepsy syndrome	2.28e-05	0.000386	CcSEcCtD
Loxapine—Dermatitis—Diazepam—epilepsy syndrome	2.28e-05	0.000386	CcSEcCtD
Loxapine—Chest pain—Pregabalin—epilepsy syndrome	2.27e-05	0.000384	CcSEcCtD
Loxapine—Dizziness—Zonisamide—epilepsy syndrome	2.27e-05	0.000384	CcSEcCtD
Loxapine—Headache—Diazepam—epilepsy syndrome	2.27e-05	0.000384	CcSEcCtD
Loxapine—Asenapine—SLC6A4—epilepsy syndrome	2.27e-05	0.0117	CrCbGaD
Loxapine—HRH1—brain—epilepsy syndrome	2.26e-05	0.000777	CbGeAlD
Loxapine—Hypotension—Valproic Acid—epilepsy syndrome	2.25e-05	0.000381	CcSEcCtD
Loxapine—Asthenia—Carbamazepine—epilepsy syndrome	2.25e-05	0.000381	CcSEcCtD
Loxapine—Agitation—Gabapentin—epilepsy syndrome	2.24e-05	0.00038	CcSEcCtD
Loxapine—Nausea—Fosphenytoin—epilepsy syndrome	2.24e-05	0.000379	CcSEcCtD
Loxapine—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.23e-05	0.000378	CcSEcCtD
Loxapine—Vomiting—Felbamate—epilepsy syndrome	2.23e-05	0.000377	CcSEcCtD
Loxapine—ADRA2A—brain—epilepsy syndrome	2.22e-05	0.000764	CbGeAlD
Loxapine—Dry mouth—Pregabalin—epilepsy syndrome	2.22e-05	0.000376	CcSEcCtD
Loxapine—Pruritus—Carbamazepine—epilepsy syndrome	2.22e-05	0.000375	CcSEcCtD
Loxapine—Clozapine—HRH3—epilepsy syndrome	2.21e-05	0.0115	CrCbGaD
Loxapine—Rash—Felbamate—epilepsy syndrome	2.21e-05	0.000374	CcSEcCtD
Loxapine—Dermatitis—Felbamate—epilepsy syndrome	2.21e-05	0.000374	CcSEcCtD
Loxapine—Headache—Felbamate—epilepsy syndrome	2.19e-05	0.000372	CcSEcCtD
Loxapine—Confusional state—Pregabalin—epilepsy syndrome	2.19e-05	0.000371	CcSEcCtD
Loxapine—Syncope—Gabapentin—epilepsy syndrome	2.19e-05	0.000371	CcSEcCtD
Loxapine—Leukopenia—Gabapentin—epilepsy syndrome	2.19e-05	0.00037	CcSEcCtD
Loxapine—Dizziness—Clonazepam—epilepsy syndrome	2.18e-05	0.00037	CcSEcCtD
Loxapine—Nausea—Vigabatrin—epilepsy syndrome	2.18e-05	0.00037	CcSEcCtD
Loxapine—Vomiting—Zonisamide—epilepsy syndrome	2.18e-05	0.000369	CcSEcCtD
Loxapine—Insomnia—Valproic Acid—epilepsy syndrome	2.17e-05	0.000368	CcSEcCtD
Loxapine—Oedema—Pregabalin—epilepsy syndrome	2.17e-05	0.000368	CcSEcCtD
Loxapine—Asthenia—Lamotrigine—epilepsy syndrome	2.17e-05	0.000368	CcSEcCtD
Loxapine—Dizziness—Phenytoin—epilepsy syndrome	2.17e-05	0.000367	CcSEcCtD
Loxapine—Fludiazepam—GABRB3—epilepsy syndrome	2.17e-05	0.0112	CrCbGaD
Loxapine—Fludiazepam—GABRA5—epilepsy syndrome	2.17e-05	0.0112	CrCbGaD
Loxapine—Rash—Zonisamide—epilepsy syndrome	2.16e-05	0.000366	CcSEcCtD
Loxapine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.16e-05	0.000366	CcSEcCtD
Loxapine—Dermatitis—Zonisamide—epilepsy syndrome	2.16e-05	0.000366	CcSEcCtD
Loxapine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.16e-05	0.000366	CcSEcCtD
Loxapine—Nausea—Diazepam—epilepsy syndrome	2.15e-05	0.000364	CcSEcCtD
Loxapine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.15e-05	0.000364	CcSEcCtD
Loxapine—Headache—Zonisamide—epilepsy syndrome	2.15e-05	0.000364	CcSEcCtD
Loxapine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.14e-05	0.000363	CcSEcCtD
Loxapine—Angiopathy—Topiramate—epilepsy syndrome	2.14e-05	0.000363	CcSEcCtD
Loxapine—Pruritus—Lamotrigine—epilepsy syndrome	2.14e-05	0.000363	CcSEcCtD
Loxapine—Shock—Pregabalin—epilepsy syndrome	2.14e-05	0.000362	CcSEcCtD
Loxapine—Somnolence—Valproic Acid—epilepsy syndrome	2.14e-05	0.000362	CcSEcCtD
Loxapine—Nervous system disorder—Pregabalin—epilepsy syndrome	2.13e-05	0.000361	CcSEcCtD
Loxapine—Cough—Gabapentin—epilepsy syndrome	2.13e-05	0.000361	CcSEcCtD
Loxapine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.13e-05	0.000361	CcSEcCtD
Loxapine—Mediastinal disorder—Topiramate—epilepsy syndrome	2.13e-05	0.00036	CcSEcCtD
Loxapine—Tachycardia—Pregabalin—epilepsy syndrome	2.12e-05	0.000359	CcSEcCtD
Loxapine—Convulsion—Gabapentin—epilepsy syndrome	2.12e-05	0.000359	CcSEcCtD
Loxapine—Prazepam—GABRA5—epilepsy syndrome	2.11e-05	0.0109	CrCbGaD
Loxapine—Prazepam—GABRB3—epilepsy syndrome	2.11e-05	0.0109	CrCbGaD
Loxapine—Hypertension—Gabapentin—epilepsy syndrome	2.11e-05	0.000357	CcSEcCtD
Loxapine—Vomiting—Clonazepam—epilepsy syndrome	2.1e-05	0.000356	CcSEcCtD
Loxapine—Alopecia—Topiramate—epilepsy syndrome	2.09e-05	0.000353	CcSEcCtD
Loxapine—Vomiting—Phenytoin—epilepsy syndrome	2.09e-05	0.000353	CcSEcCtD
Loxapine—Rash—Clonazepam—epilepsy syndrome	2.08e-05	0.000353	CcSEcCtD
Loxapine—Dermatitis—Clonazepam—epilepsy syndrome	2.08e-05	0.000352	CcSEcCtD
Loxapine—Chest pain—Gabapentin—epilepsy syndrome	2.08e-05	0.000352	CcSEcCtD
Loxapine—Nausea—Felbamate—epilepsy syndrome	2.08e-05	0.000352	CcSEcCtD
Loxapine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.08e-05	0.000352	CcSEcCtD
Loxapine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.07e-05	0.000351	CcSEcCtD
Loxapine—Fatigue—Valproic Acid—epilepsy syndrome	2.07e-05	0.000351	CcSEcCtD
Loxapine—Dizziness—Carbamazepine—epilepsy syndrome	2.07e-05	0.000351	CcSEcCtD
Loxapine—Headache—Clonazepam—epilepsy syndrome	2.07e-05	0.00035	CcSEcCtD
Loxapine—Rash—Phenytoin—epilepsy syndrome	2.07e-05	0.00035	CcSEcCtD
Loxapine—Dermatitis—Phenytoin—epilepsy syndrome	2.07e-05	0.00035	CcSEcCtD
Loxapine—Rash—Oxcarbazepine—epilepsy syndrome	2.06e-05	0.000349	CcSEcCtD
Loxapine—Constipation—Valproic Acid—epilepsy syndrome	2.06e-05	0.000348	CcSEcCtD
Loxapine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.06e-05	0.000348	CcSEcCtD
Loxapine—Headache—Phenytoin—epilepsy syndrome	2.06e-05	0.000348	CcSEcCtD
Loxapine—Headache—Oxcarbazepine—epilepsy syndrome	2.04e-05	0.000346	CcSEcCtD
Loxapine—Nausea—Zonisamide—epilepsy syndrome	2.04e-05	0.000345	CcSEcCtD
Loxapine—Dry mouth—Gabapentin—epilepsy syndrome	2.03e-05	0.000345	CcSEcCtD
Loxapine—Hypotension—Pregabalin—epilepsy syndrome	2.03e-05	0.000344	CcSEcCtD
Loxapine—Amoxapine—GABRA1—epilepsy syndrome	2.02e-05	0.0105	CrCbGaD
Loxapine—Tension—Topiramate—epilepsy syndrome	2.02e-05	0.000342	CcSEcCtD
Loxapine—Dysgeusia—Topiramate—epilepsy syndrome	2.01e-05	0.000341	CcSEcCtD
Loxapine—Confusional state—Gabapentin—epilepsy syndrome	2.01e-05	0.000341	CcSEcCtD
Loxapine—Dizziness—Lamotrigine—epilepsy syndrome	2e-05	0.000339	CcSEcCtD
Loxapine—Cyproheptadine—CHRM2—epilepsy syndrome	2e-05	0.0103	CrCbGaD
Loxapine—Oedema—Gabapentin—epilepsy syndrome	1.99e-05	0.000338	CcSEcCtD
Loxapine—Vomiting—Carbamazepine—epilepsy syndrome	1.99e-05	0.000337	CcSEcCtD
Loxapine—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.98e-05	0.000336	CcSEcCtD
Loxapine—Muscle spasms—Topiramate—epilepsy syndrome	1.98e-05	0.000335	CcSEcCtD
Loxapine—Rash—Carbamazepine—epilepsy syndrome	1.97e-05	0.000334	CcSEcCtD
Loxapine—Dermatitis—Carbamazepine—epilepsy syndrome	1.97e-05	0.000334	CcSEcCtD
Loxapine—Insomnia—Pregabalin—epilepsy syndrome	1.97e-05	0.000333	CcSEcCtD
Loxapine—Nausea—Clonazepam—epilepsy syndrome	1.96e-05	0.000332	CcSEcCtD
Loxapine—Headache—Carbamazepine—epilepsy syndrome	1.96e-05	0.000332	CcSEcCtD
Loxapine—Shock—Gabapentin—epilepsy syndrome	1.96e-05	0.000332	CcSEcCtD
Loxapine—Nervous system disorder—Gabapentin—epilepsy syndrome	1.96e-05	0.000331	CcSEcCtD
Loxapine—Paraesthesia—Pregabalin—epilepsy syndrome	1.95e-05	0.000331	CcSEcCtD
Loxapine—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.95e-05	0.000331	CcSEcCtD
Loxapine—Nausea—Phenytoin—epilepsy syndrome	1.95e-05	0.00033	CcSEcCtD
Loxapine—Tachycardia—Gabapentin—epilepsy syndrome	1.95e-05	0.00033	CcSEcCtD
Loxapine—Diazepam—GABRG2—epilepsy syndrome	1.94e-05	0.0101	CrCbGaD
Loxapine—Dyspnoea—Pregabalin—epilepsy syndrome	1.94e-05	0.000328	CcSEcCtD
Loxapine—Nausea—Oxcarbazepine—epilepsy syndrome	1.94e-05	0.000328	CcSEcCtD
Loxapine—Vision blurred—Topiramate—epilepsy syndrome	1.94e-05	0.000328	CcSEcCtD
Loxapine—Olanzapine—CHRM2—epilepsy syndrome	1.94e-05	0.01	CrCbGaD
Loxapine—Somnolence—Pregabalin—epilepsy syndrome	1.93e-05	0.000327	CcSEcCtD
Loxapine—Olanzapine—HTR7—epilepsy syndrome	1.93e-05	0.00997	CrCbGaD
Loxapine—Tremor—Topiramate—epilepsy syndrome	1.93e-05	0.000326	CcSEcCtD
Loxapine—Vomiting—Lamotrigine—epilepsy syndrome	1.92e-05	0.000326	CcSEcCtD
Loxapine—Rash—Lamotrigine—epilepsy syndrome	1.91e-05	0.000323	CcSEcCtD
Loxapine—Dermatitis—Lamotrigine—epilepsy syndrome	1.91e-05	0.000323	CcSEcCtD
Loxapine—Headache—Lamotrigine—epilepsy syndrome	1.9e-05	0.000321	CcSEcCtD
Loxapine—Fludiazepam—GABRB2—epilepsy syndrome	1.89e-05	0.00981	CrCbGaD
Loxapine—HTR2A—brain—epilepsy syndrome	1.89e-05	0.000649	CbGeAlD
Loxapine—Agitation—Topiramate—epilepsy syndrome	1.89e-05	0.00032	CcSEcCtD
Loxapine—Amoxapine—CHRM1—epilepsy syndrome	1.89e-05	0.00977	CrCbGaD
Loxapine—Temazepam—GABRB3—epilepsy syndrome	1.88e-05	0.00975	CrCbGaD
Loxapine—Temazepam—GABRA5—epilepsy syndrome	1.88e-05	0.00975	CrCbGaD
Loxapine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.88e-05	0.000318	CcSEcCtD
Loxapine—Fatigue—Pregabalin—epilepsy syndrome	1.87e-05	0.000318	CcSEcCtD
Loxapine—Hypotension—Gabapentin—epilepsy syndrome	1.86e-05	0.000316	CcSEcCtD
Loxapine—Nausea—Carbamazepine—epilepsy syndrome	1.86e-05	0.000315	CcSEcCtD
Loxapine—Constipation—Pregabalin—epilepsy syndrome	1.86e-05	0.000315	CcSEcCtD
Loxapine—Fludiazepam—GABRA1—epilepsy syndrome	1.86e-05	0.00962	CrCbGaD
Loxapine—Prazepam—GABRB2—epilepsy syndrome	1.85e-05	0.00957	CrCbGaD
Loxapine—Syncope—Topiramate—epilepsy syndrome	1.84e-05	0.000312	CcSEcCtD
Loxapine—Leukopenia—Topiramate—epilepsy syndrome	1.84e-05	0.000312	CcSEcCtD
Loxapine—Prazepam—GABRA1—epilepsy syndrome	1.81e-05	0.00939	CrCbGaD
Loxapine—Loss of consciousness—Topiramate—epilepsy syndrome	1.81e-05	0.000306	CcSEcCtD
Loxapine—Insomnia—Gabapentin—epilepsy syndrome	1.8e-05	0.000305	CcSEcCtD
Loxapine—Nausea—Lamotrigine—epilepsy syndrome	1.8e-05	0.000305	CcSEcCtD
Loxapine—Cough—Topiramate—epilepsy syndrome	1.79e-05	0.000304	CcSEcCtD
Loxapine—Feeling abnormal—Pregabalin—epilepsy syndrome	1.79e-05	0.000303	CcSEcCtD
Loxapine—Paraesthesia—Gabapentin—epilepsy syndrome	1.79e-05	0.000303	CcSEcCtD
Loxapine—Convulsion—Topiramate—epilepsy syndrome	1.78e-05	0.000302	CcSEcCtD
Loxapine—Dyspnoea—Gabapentin—epilepsy syndrome	1.78e-05	0.000301	CcSEcCtD
Loxapine—Hypertension—Topiramate—epilepsy syndrome	1.77e-05	0.000301	CcSEcCtD
Loxapine—Somnolence—Gabapentin—epilepsy syndrome	1.77e-05	0.0003	CcSEcCtD
Loxapine—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.77e-05	0.0003	CcSEcCtD
Loxapine—Chest pain—Topiramate—epilepsy syndrome	1.75e-05	0.000296	CcSEcCtD
Loxapine—Asenapine—HTR2A—epilepsy syndrome	1.74e-05	0.00901	CrCbGaD
Loxapine—Zuclopenthixol—ADRA2A—epilepsy syndrome	1.74e-05	0.00898	CrCbGaD
Loxapine—Asthenia—Valproic Acid—epilepsy syndrome	1.73e-05	0.000292	CcSEcCtD
Loxapine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.72e-05	0.000292	CcSEcCtD
Loxapine—Fatigue—Gabapentin—epilepsy syndrome	1.72e-05	0.000291	CcSEcCtD
Loxapine—Dry mouth—Topiramate—epilepsy syndrome	1.71e-05	0.00029	CcSEcCtD
Loxapine—Constipation—Gabapentin—epilepsy syndrome	1.7e-05	0.000289	CcSEcCtD
Loxapine—Pruritus—Valproic Acid—epilepsy syndrome	1.7e-05	0.000288	CcSEcCtD
Loxapine—Confusional state—Topiramate—epilepsy syndrome	1.69e-05	0.000286	CcSEcCtD
Loxapine—Oedema—Topiramate—epilepsy syndrome	1.68e-05	0.000284	CcSEcCtD
Loxapine—Prochlorperazine—CHRM2—epilepsy syndrome	1.67e-05	0.00867	CrCbGaD
Loxapine—Olanzapine—ADRA2A—epilepsy syndrome	1.65e-05	0.00855	CrCbGaD
Loxapine—Shock—Topiramate—epilepsy syndrome	1.65e-05	0.00028	CcSEcCtD
Loxapine—Temazepam—GABRB2—epilepsy syndrome	1.65e-05	0.00854	CrCbGaD
Loxapine—Nervous system disorder—Topiramate—epilepsy syndrome	1.64e-05	0.000279	CcSEcCtD
Loxapine—Feeling abnormal—Gabapentin—epilepsy syndrome	1.64e-05	0.000278	CcSEcCtD
Loxapine—Thrombocytopenia—Topiramate—epilepsy syndrome	1.64e-05	0.000278	CcSEcCtD
Loxapine—Tachycardia—Topiramate—epilepsy syndrome	1.64e-05	0.000277	CcSEcCtD
Loxapine—Temazepam—GABRA1—epilepsy syndrome	1.62e-05	0.00837	CrCbGaD
Loxapine—Hypersensitivity—Pregabalin—epilepsy syndrome	1.6e-05	0.000271	CcSEcCtD
Loxapine—Trazodone—ADRA2A—epilepsy syndrome	1.6e-05	0.00826	CrCbGaD
Loxapine—Asenapine—CYP2D6—epilepsy syndrome	1.59e-05	0.00824	CrCbGaD
Loxapine—Dizziness—Valproic Acid—epilepsy syndrome	1.59e-05	0.000269	CcSEcCtD
Loxapine—Hypotension—Topiramate—epilepsy syndrome	1.57e-05	0.000265	CcSEcCtD
Loxapine—Diazepam—GABRB3—epilepsy syndrome	1.57e-05	0.0081	CrCbGaD
Loxapine—Diazepam—GABRA5—epilepsy syndrome	1.57e-05	0.0081	CrCbGaD
Loxapine—Asthenia—Pregabalin—epilepsy syndrome	1.56e-05	0.000264	CcSEcCtD
Loxapine—Quetiapine—CHRM3—epilepsy syndrome	1.54e-05	0.00798	CrCbGaD
Loxapine—Pruritus—Pregabalin—epilepsy syndrome	1.54e-05	0.000261	CcSEcCtD
Loxapine—Amoxapine—HTR7—epilepsy syndrome	1.53e-05	0.00794	CrCbGaD
Loxapine—Vomiting—Valproic Acid—epilepsy syndrome	1.53e-05	0.000259	CcSEcCtD
Loxapine—Insomnia—Topiramate—epilepsy syndrome	1.52e-05	0.000257	CcSEcCtD
Loxapine—Rash—Valproic Acid—epilepsy syndrome	1.52e-05	0.000257	CcSEcCtD
Loxapine—Dermatitis—Valproic Acid—epilepsy syndrome	1.51e-05	0.000257	CcSEcCtD
Loxapine—Headache—Valproic Acid—epilepsy syndrome	1.51e-05	0.000255	CcSEcCtD
Loxapine—Paraesthesia—Topiramate—epilepsy syndrome	1.51e-05	0.000255	CcSEcCtD
Loxapine—Thiothixene—ADRA2A—epilepsy syndrome	1.5e-05	0.00774	CrCbGaD
Loxapine—Dyspnoea—Topiramate—epilepsy syndrome	1.5e-05	0.000253	CcSEcCtD
Loxapine—Somnolence—Topiramate—epilepsy syndrome	1.49e-05	0.000253	CcSEcCtD
Loxapine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.47e-05	0.000249	CcSEcCtD
Loxapine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.45e-05	0.000245	CcSEcCtD
Loxapine—Fatigue—Topiramate—epilepsy syndrome	1.45e-05	0.000245	CcSEcCtD
Loxapine—Quetiapine—CHRM1—epilepsy syndrome	1.44e-05	0.00745	CrCbGaD
Loxapine—Dizziness—Pregabalin—epilepsy syndrome	1.44e-05	0.000244	CcSEcCtD
Loxapine—Constipation—Topiramate—epilepsy syndrome	1.43e-05	0.000243	CcSEcCtD
Loxapine—Asthenia—Gabapentin—epilepsy syndrome	1.43e-05	0.000242	CcSEcCtD
Loxapine—Nausea—Valproic Acid—epilepsy syndrome	1.43e-05	0.000242	CcSEcCtD
Loxapine—Pruritus—Gabapentin—epilepsy syndrome	1.41e-05	0.000239	CcSEcCtD
Loxapine—Azelastine—CYP2C19—epilepsy syndrome	1.39e-05	0.0072	CrCbGaD
Loxapine—Vomiting—Pregabalin—epilepsy syndrome	1.38e-05	0.000234	CcSEcCtD
Loxapine—Feeling abnormal—Topiramate—epilepsy syndrome	1.38e-05	0.000234	CcSEcCtD
Loxapine—Rash—Pregabalin—epilepsy syndrome	1.37e-05	0.000232	CcSEcCtD
Loxapine—Diazepam—GABRB2—epilepsy syndrome	1.37e-05	0.00709	CrCbGaD
Loxapine—Dermatitis—Pregabalin—epilepsy syndrome	1.37e-05	0.000232	CcSEcCtD
Loxapine—Headache—Pregabalin—epilepsy syndrome	1.36e-05	0.000231	CcSEcCtD
Loxapine—Diazepam—GABRA1—epilepsy syndrome	1.34e-05	0.00695	CrCbGaD
Loxapine—Clozapine—CHRM3—epilepsy syndrome	1.33e-05	0.00687	CrCbGaD
Loxapine—Dizziness—Gabapentin—epilepsy syndrome	1.32e-05	0.000223	CcSEcCtD
Loxapine—Amoxapine—ADRA2A—epilepsy syndrome	1.31e-05	0.00681	CrCbGaD
Loxapine—Nausea—Pregabalin—epilepsy syndrome	1.29e-05	0.000219	CcSEcCtD
Loxapine—Vomiting—Gabapentin—epilepsy syndrome	1.27e-05	0.000215	CcSEcCtD
Loxapine—Rash—Gabapentin—epilepsy syndrome	1.26e-05	0.000213	CcSEcCtD
Loxapine—Dermatitis—Gabapentin—epilepsy syndrome	1.26e-05	0.000213	CcSEcCtD
Loxapine—Headache—Gabapentin—epilepsy syndrome	1.25e-05	0.000212	CcSEcCtD
Loxapine—Clozapine—CHRM1—epilepsy syndrome	1.24e-05	0.0064	CrCbGaD
Loxapine—Hypersensitivity—Topiramate—epilepsy syndrome	1.24e-05	0.000209	CcSEcCtD
Loxapine—Trazodone—SLC6A4—epilepsy syndrome	1.22e-05	0.0063	CrCbGaD
Loxapine—Trifluoperazine—CHRM2—epilepsy syndrome	1.21e-05	0.00627	CrCbGaD
Loxapine—Asthenia—Topiramate—epilepsy syndrome	1.2e-05	0.000204	CcSEcCtD
Loxapine—Olanzapine—CYP2C19—epilepsy syndrome	1.19e-05	0.00618	CrCbGaD
Loxapine—Pruritus—Topiramate—epilepsy syndrome	1.19e-05	0.000201	CcSEcCtD
Loxapine—Nausea—Gabapentin—epilepsy syndrome	1.18e-05	0.000201	CcSEcCtD
Loxapine—Quetiapine—CHRM2—epilepsy syndrome	1.17e-05	0.00608	CrCbGaD
Loxapine—Quetiapine—HTR7—epilepsy syndrome	1.17e-05	0.00605	CrCbGaD
Loxapine—Dizziness—Topiramate—epilepsy syndrome	1.11e-05	0.000188	CcSEcCtD
Loxapine—Clobazam—CYP2C19—epilepsy syndrome	1.08e-05	0.0056	CrCbGaD
Loxapine—Vomiting—Topiramate—epilepsy syndrome	1.07e-05	0.000181	CcSEcCtD
Loxapine—Rash—Topiramate—epilepsy syndrome	1.06e-05	0.000179	CcSEcCtD
Loxapine—Dermatitis—Topiramate—epilepsy syndrome	1.06e-05	0.000179	CcSEcCtD
Loxapine—Headache—Topiramate—epilepsy syndrome	1.05e-05	0.000178	CcSEcCtD
Loxapine—Azelastine—CYP2D6—epilepsy syndrome	1.03e-05	0.00534	CrCbGaD
Loxapine—Zuclopenthixol—HTR2A—epilepsy syndrome	1.02e-05	0.00527	CrCbGaD
Loxapine—Clozapine—CHRM2—epilepsy syndrome	1.01e-05	0.00523	CrCbGaD
Loxapine—Clozapine—HTR7—epilepsy syndrome	1.01e-05	0.0052	CrCbGaD
Loxapine—Amoxapine—SLC6A4—epilepsy syndrome	1e-05	0.00519	CrCbGaD
Loxapine—Quetiapine—ADRA2A—epilepsy syndrome	1e-05	0.00519	CrCbGaD
Loxapine—Cyproheptadine—HTR2A—epilepsy syndrome	1e-05	0.00518	CrCbGaD
Loxapine—Nausea—Topiramate—epilepsy syndrome	9.96e-06	0.000169	CcSEcCtD
Loxapine—Olanzapine—HTR2A—epilepsy syndrome	9.69e-06	0.00501	CrCbGaD
Loxapine—Chlordiazepoxide—CYP2D6—epilepsy syndrome	9.47e-06	0.0049	CrCbGaD
Loxapine—Trazodone—HTR2A—epilepsy syndrome	9.36e-06	0.00484	CrCbGaD
Loxapine—Zuclopenthixol—CYP2D6—epilepsy syndrome	9.3e-06	0.00482	CrCbGaD
Loxapine—Olanzapine—CYP2D6—epilepsy syndrome	8.86e-06	0.00458	CrCbGaD
Loxapine—Thiothixene—HTR2A—epilepsy syndrome	8.77e-06	0.00454	CrCbGaD
Loxapine—Clozapine—ADRA2A—epilepsy syndrome	8.62e-06	0.00446	CrCbGaD
Loxapine—Trazodone—CYP2D6—epilepsy syndrome	8.56e-06	0.00443	CrCbGaD
Loxapine—Thiothixene—CYP2D6—epilepsy syndrome	8.02e-06	0.00415	CrCbGaD
Loxapine—Amoxapine—HTR2A—epilepsy syndrome	7.71e-06	0.00399	CrCbGaD
Loxapine—Prochlorperazine—CYP2D6—epilepsy syndrome	7.66e-06	0.00397	CrCbGaD
Loxapine—Temazepam—CYP2C19—epilepsy syndrome	7.6e-06	0.00393	CrCbGaD
Loxapine—Azelastine—ABCB1—epilepsy syndrome	7.36e-06	0.00381	CrCbGaD
Loxapine—Quetiapine—CYP2C19—epilepsy syndrome	7.25e-06	0.00375	CrCbGaD
Loxapine—Amoxapine—CYP2D6—epilepsy syndrome	7.05e-06	0.00365	CrCbGaD
Loxapine—Olanzapine—ALB—epilepsy syndrome	6.63e-06	0.00343	CrCbGaD
Loxapine—Olanzapine—ABCB1—epilepsy syndrome	6.32e-06	0.00327	CrCbGaD
Loxapine—Diazepam—CYP2C19—epilepsy syndrome	6.31e-06	0.00327	CrCbGaD
Loxapine—Clozapine—CYP2C19—epilepsy syndrome	6.24e-06	0.00323	CrCbGaD
Loxapine—Trazodone—ABCB1—epilepsy syndrome	6.11e-06	0.00316	CrCbGaD
Loxapine—Trifluoperazine—HTR2A—epilepsy syndrome	6.06e-06	0.00314	CrCbGaD
Loxapine—Thiothixene—ALB—epilepsy syndrome	6e-06	0.00311	CrCbGaD
Loxapine—Quetiapine—HTR2A—epilepsy syndrome	5.88e-06	0.00304	CrCbGaD
Loxapine—Clobazam—ABCB1—epilepsy syndrome	5.73e-06	0.00296	CrCbGaD
Loxapine—Quetiapine—CYP2D6—epilepsy syndrome	5.37e-06	0.00278	CrCbGaD
Loxapine—Clozapine—HTR2A—epilepsy syndrome	5.05e-06	0.00262	CrCbGaD
Loxapine—Clozapine—CYP2D6—epilepsy syndrome	4.62e-06	0.00239	CrCbGaD
Loxapine—Trifluoperazine—ABCB1—epilepsy syndrome	3.96e-06	0.00205	CrCbGaD
Loxapine—Quetiapine—ABCB1—epilepsy syndrome	3.84e-06	0.00199	CrCbGaD
Loxapine—Diazepam—ALB—epilepsy syndrome	3.5e-06	0.00181	CrCbGaD
Loxapine—Diazepam—ABCB1—epilepsy syndrome	3.34e-06	0.00173	CrCbGaD
Loxapine—Clozapine—ABCB1—epilepsy syndrome	3.3e-06	0.00171	CrCbGaD
Loxapine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	3.16e-07	6.09e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	3.16e-07	6.09e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	3.15e-07	6.08e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—ALB—epilepsy syndrome	3.15e-07	6.08e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	3.15e-07	6.07e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	3.14e-07	6.06e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	3.14e-07	6.06e-06	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	3.13e-07	6.05e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—JUN—epilepsy syndrome	3.13e-07	6.04e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	3.13e-07	6.04e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	3.13e-07	6.03e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	3.12e-07	6.02e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	3.12e-07	6.01e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	3.11e-07	6.01e-06	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	3.11e-07	6.01e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	3.1e-07	5.98e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	3.09e-07	5.96e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	3.09e-07	5.96e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	3.09e-07	5.96e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	3.09e-07	5.96e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	3.08e-07	5.95e-06	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	3.07e-07	5.93e-06	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—AKT1—epilepsy syndrome	3.07e-07	5.92e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	3.07e-07	5.92e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	3.05e-07	5.88e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	3.05e-07	5.88e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	3.02e-07	5.83e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	3.01e-07	5.8e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	3e-07	5.8e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	2.98e-07	5.75e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	2.97e-07	5.72e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	2.96e-07	5.71e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	2.96e-07	5.71e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	2.96e-07	5.7e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	2.94e-07	5.67e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—SRC—epilepsy syndrome	2.94e-07	5.66e-06	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.93e-07	5.65e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	2.92e-07	5.63e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	2.92e-07	5.63e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	2.91e-07	5.62e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.91e-07	5.61e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	2.91e-07	5.61e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	2.9e-07	5.6e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.9e-07	5.59e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.9e-07	5.59e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	2.9e-07	5.59e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	2.89e-07	5.58e-06	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.89e-07	5.58e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—ALB—epilepsy syndrome	2.89e-07	5.58e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.89e-07	5.57e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	2.89e-07	5.57e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.88e-07	5.56e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	2.87e-07	5.53e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	2.86e-07	5.53e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	2.86e-07	5.52e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.86e-07	5.52e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	2.86e-07	5.52e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	2.86e-07	5.51e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	2.85e-07	5.5e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	2.85e-07	5.5e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	2.84e-07	5.49e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	2.84e-07	5.48e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	2.84e-07	5.48e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	2.84e-07	5.48e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.83e-07	5.47e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.83e-07	5.45e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	2.82e-07	5.44e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	2.81e-07	5.43e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—SRC—epilepsy syndrome	2.81e-07	5.42e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.8e-07	5.4e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.79e-07	5.39e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	2.79e-07	5.38e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	2.78e-07	5.37e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.78e-07	5.37e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	2.77e-07	5.35e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	2.77e-07	5.34e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.75e-07	5.32e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	2.75e-07	5.31e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	2.74e-07	5.29e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	2.74e-07	5.28e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	2.71e-07	5.24e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	2.71e-07	5.22e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	2.7e-07	5.21e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	2.7e-07	5.21e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	2.68e-07	5.17e-06	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	2.67e-07	5.16e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	2.66e-07	5.13e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	2.65e-07	5.12e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	2.65e-07	5.11e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	2.64e-07	5.09e-06	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.63e-07	5.08e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	2.63e-07	5.07e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	2.63e-07	5.07e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	2.62e-07	5.05e-06	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.61e-07	5.04e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	2.61e-07	5.04e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	2.59e-07	5e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	2.59e-07	4.99e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	2.59e-07	4.99e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	2.58e-07	4.99e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	2.58e-07	4.97e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	2.57e-07	4.96e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.56e-07	4.94e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.55e-07	4.93e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	2.54e-07	4.89e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	2.53e-07	4.88e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.53e-07	4.88e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	2.53e-07	4.88e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	2.52e-07	4.87e-06	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.52e-07	4.86e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	2.51e-07	4.85e-06	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.51e-07	4.84e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	2.5e-07	4.82e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	2.5e-07	4.82e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	2.48e-07	4.79e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	2.47e-07	4.76e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	2.46e-07	4.75e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	2.44e-07	4.72e-06	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.44e-07	4.7e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	2.43e-07	4.69e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	2.43e-07	4.69e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	2.42e-07	4.68e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	2.42e-07	4.66e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	2.41e-07	4.65e-06	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.4e-07	4.63e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	2.39e-07	4.62e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	2.39e-07	4.61e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	2.39e-07	4.6e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	2.38e-07	4.6e-06	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	2.38e-07	4.59e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.38e-07	4.59e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	2.38e-07	4.59e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.37e-07	4.57e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	2.37e-07	4.57e-06	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	2.37e-07	4.56e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	2.36e-07	4.55e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.35e-07	4.53e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	2.35e-07	4.53e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	2.35e-07	4.53e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	2.34e-07	4.52e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	2.34e-07	4.52e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	2.34e-07	4.52e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	2.34e-07	4.51e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.33e-07	4.5e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.32e-07	4.49e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	2.31e-07	4.46e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.3e-07	4.44e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	2.3e-07	4.43e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.29e-07	4.41e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	2.28e-07	4.4e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.28e-07	4.39e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	2.27e-07	4.39e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	2.25e-07	4.35e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	2.25e-07	4.34e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	2.21e-07	4.27e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.21e-07	4.27e-06	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.21e-07	4.27e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.19e-07	4.23e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	2.19e-07	4.23e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	2.18e-07	4.2e-06	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.18e-07	4.2e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	2.18e-07	4.2e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	2.18e-07	4.2e-06	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.17e-07	4.19e-06	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.17e-07	4.18e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	2.16e-07	4.18e-06	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.16e-07	4.16e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	2.16e-07	4.16e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.15e-07	4.15e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.15e-07	4.14e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.14e-07	4.13e-06	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.14e-07	4.12e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	2.13e-07	4.12e-06	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.13e-07	4.11e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	2.13e-07	4.11e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.12e-07	4.09e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.12e-07	4.09e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	2.11e-07	4.07e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.11e-07	4.07e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	2.1e-07	4.06e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	2.09e-07	4.04e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.09e-07	4.03e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.08e-07	4.02e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.08e-07	4.01e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	2.07e-07	4e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	2.07e-07	4e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.06e-07	3.97e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.05e-07	3.96e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.05e-07	3.96e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.04e-07	3.93e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.03e-07	3.92e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.03e-07	3.91e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.02e-07	3.9e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.02e-07	3.89e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	2.01e-07	3.88e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2e-07	3.86e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2e-07	3.85e-06	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.98e-07	3.82e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.98e-07	3.81e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	1.97e-07	3.81e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.97e-07	3.79e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.96e-07	3.79e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.96e-07	3.78e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.94e-07	3.74e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.94e-07	3.73e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.91e-07	3.68e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.91e-07	3.68e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.88e-07	3.63e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	1.87e-07	3.62e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.87e-07	3.61e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.86e-07	3.59e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.86e-07	3.59e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.85e-07	3.58e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.84e-07	3.56e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	1.84e-07	3.55e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.83e-07	3.53e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	1.83e-07	3.52e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	1.83e-07	3.52e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	1.82e-07	3.52e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.82e-07	3.51e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.81e-07	3.5e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	1.81e-07	3.5e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.8e-07	3.47e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.8e-07	3.47e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.79e-07	3.46e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	1.77e-07	3.42e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	1.75e-07	3.37e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	1.72e-07	3.32e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.71e-07	3.3e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.66e-07	3.21e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.65e-07	3.18e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	1.57e-07	3.03e-06	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	1.56e-07	3.02e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	1.55e-07	2.99e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	1.41e-07	2.73e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.4e-07	2.7e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.38e-07	2.67e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.35e-07	2.61e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.34e-07	2.59e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.31e-07	2.52e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.29e-07	2.48e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.27e-07	2.45e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.19e-07	2.29e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.17e-07	2.25e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.17e-07	2.25e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.16e-07	2.24e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.16e-07	2.23e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.15e-07	2.21e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.14e-07	2.21e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.06e-07	2.05e-06	CbGpPWpGaD
